Results In the Kyushu University group, a favourable histology was diagnosed in 80% of patients and an unfavourable histology in 20% of patients. The distribution of the clinical stage was as follows: I = 40%, II = 22.5%, III = 22.5%, IV = 7.5% and V = 7.5%. The 5-year overall survival was 82.5%, with the 5-year stage-related survival as follows: I = 93.7%, II = 83.3%, III = 62.5%, IV = 33.3% and V = 100%. In the South Egypt Cancer Institute group, favourable histology was diagnosed in 89.9% of patients, unfavourable histology in 8.8% of patients and benign disease in 1.3% of patients. The distribution of the clinical stage (before and after chemotherapy) was as follows: I = 25.3%-50%, II = 19%-20%, III = 35.4-15%, IV = 12.5%-5% and V = 7.6%-7.6%. No case of intraoperative tumour rupture was recorded. The overall 5-year survival rate of 84% with a 5-year stage-related survival was as follows: I = 92%, II = 80%, III = 50%, IV = 31% and V = 30%. In the Assiut University group, a favourable histology was diagnosed in 79% of patients and an unfavourable histology in 9% of patients. The distribution of the clinical stage was as follows: I = 39.4%, II = 21.2%, III = 21.2%, IV = 12% and V = 6%. The overall 5-year survival rate was 77% and the 5-year stage-related survival was as follows: I = 85%, II = 75%, III = 52%, IV = 33% and V = 33%.
Conclusion
The Egyptian patients with Wilm's tumour presented at a younger age and had less incidence of an unfavourable histology compared with Japanese patients. Preoperative chemotherapy increased the rate of stage I disease and decreased the incidence of intraoperative tumour rupture and relapse. However, there was a possibility that chemotherapy had been administered in the case of benign disease. Ann Pediatr Surg 9:25-30 c 2013 Annals of Pediatric Surgery.
Introduction
Renal tumours account for about 12% of childhood tumours [1] . Wilm's tumour is the most common renal tumour of infancy and childhood. Its incidence varies according to race, from 2.5 per million Chinese to 10.9 per million American black children [2] . It is most usually a unilateral disease, but in 5-10% of cases, both kidneys are affected [3] .
Over the past two decades, there has been a significant improvement in the survival of children with cancer in general and those with Wilm's tumours in particular; this is largely attributed to multicentric prospective studies carried out by the National Wilm's Tumour Study (NWTS) group and the International Society of Paediatric Oncology (SIOP) [4] .
The timing of surgery in relation to chemotherapy is still controversial in the management of patients with Wilm's tumours. According to the NWTS protocol, these children should be treated first by surgery, followed by chemotherapy with or without radiotherapy, depending on the stage [5] . The SIOP group, in contrast, advocates preoperative chemotherapy, followed by surgery. This approach is an attempt to decrease the size of the tumour and thus reduce the risk of intraoperative rupture; however, the survival in both groups is similar [6] .
Here, we report the characteristics of Wilm's tumours and the results of the multimodality treatment in three groups of patients with Wilm's tumours from different racial backgrounds and different therapeutic strategies. The medical records of patients were reviewed for age at diagnosis, sex, incidence, presenting symptoms, preoperative chemotherapy treatment, type of surgery, histopathological diagnosis, stage (on the basis of the NWTS and JWiTS staging system for the Kyushu and Assiut Universities groups and the SIOP staging system for the SECI group) and final outcome.
Approval was obtained from the institute review board of the participating centers.
Operative technique
A transverse supraumbilical muscle cutting transperitoneal incision, and exploration of the liver, spleen, peritoneal surface and contralateral kidney for the presence of metastasis and a synchronous Wilm's tumour were performed. Mobilization of the colon and mesentery medially and early ligation of the vascular pedicle before extensive mobilization of the tumour is recommended if possible. Ligation of artery and vein separately and the artery before the vein, radical nephrectomy and paraaortic lymph node sampling were performed.
Radiotherapy
Radiotherapy doses and indications are as follows: 10. Their ages ranged from 7 months to 5 years, mean age 24 months. Forty seven (59.5%) of the patients were below 2 years at the time of diagnosis. The modes of presentation of patients with Wilm's tumour in this group are shown in Table 1 , 85% of the patients presented with an abdominal mass and/or distention. In thirty (38%) patients, the Wilm's tumour was located in the right kidney, in 43 (54.4%) patients, the Wilm's tumour was located on the left side and in six (7.6%) patients, synchronous Wilm's Tumours were reported.
The distribution of the clinical stage (before and after chemotherapy) was as follows: I = 25.3%-50%, II = 19%-20%, III = 35.4-15%, IV = 12.6%-5% and V = 7.6%-7.6% (Fig. 1) ; there was an increase in the number of patients with stage I disease after chemotherapy. The pathology is shown in Table 1 .
Incomplete resection was encountered in three patients (4%) and relapse occurred in four (5%). With a median follow-up of 70 months, the 5-year overall survival was 84%. When all patients are considered (without exclusion of patients lost follow up) and when abandonment included the overall survival was 80%. Intraoperative tumour rupture was encountered in seven (21%) patients; three of these developed recurrence.
Incomplete resection was reported in 10 (30%) patients; four of these developed recurrence.
The pathological diagnosis is shown in Table 2 . Postoperative recurrence was reported in seven (21.2%) patients. The 5-year overall survival was 77%. The 5-year stage-related survival as follows: I = 85%, II = 75%, III = 52%, IV = 33% and V = 33%.
Discussion
Wilm's tumour is the most common embryonic malignancy of renal origin [6] . The survival rate of children with Wilm's tumours has improved considerably since the prospective randomized trials conducted by the NWTSG, SIOP and the UKCCSG. Although the overall management of children with Wilm's tumours is one of the great success stories in cancer therapy and currently more than 90% of children survive 4 years after their diagnosis, there is still room for improvement [7] .
The median age in our series was 3, 2.5 and 2 years for the KU group, the AU group and the SECI group, respectively, which is almost the same as that reported in other series [8] [9] [10] [11] [12] [13] [14] [15] . More than 59.5% of SECI patients, 47.5% of KU patients and 51.5% of AU patients are below 2 years at presentation, whereas 95, 72.5 and 84.8% of SECI, KU and AU groups, respectively, are below 4 years at presentation; these are in agreement with the results of Weirch et al. [16] . Although Grabois and Mendonca [17] and Carli et al. [18] reported age below 2 and 4 years as follow 22.7%, 55.3% and 11%, 74.2%, respectively [16, 17] . The age of Egyptian patients is younger than Japanese patients; this may be because of racial and genetic causes, but in both groups, the age of most patients is below 4 years, which is similar to that reported in previous studies.
The sex ratio in the current study was the same for both Japanese and Egyptian patients, which is similar to that reported in most other series [8, 11, [19] [20] [21] , although the sex ratio reported from some developing countries shows a slight male predominance [9, 10, 13, 14] .
The main presenting symptom of our study was an abdominal mass and/or distension, found in 72% of KU patients, which is similar to that reported in the first Wilm's tumour study of UKCCSG and a study from a South African Center; these rates were 74 and 77%, respectively [22, 23] , however, in SECI patients and AU patients the abdominal mass as presenting symptoms are 85% and 82% respectively, these rates were similar to rate reported by other studies [9, 15] . However, Yildiz et al. [8] (Turkey) and Madani et al. [10] (Morocco) reported a 95% and 97% rate of presence of an abdominal mass as presenting symptoms, respectively. There is a higher incidence of an abdominal mass and/or distension in SECI and AU patients; this may be because of a delayed diagnosis.
The stage I percentage in our study was 50% for the SECI group (postchemotherapy), 40% for the KU group and 33.3% for the AU group; this difference was because of the preoperative chemotherapy treatment that was provided for SECI patients. The percentage of stage I for SECI patients is almost the same as that reported in Morocco by Madani et al. (50%) [8] and slightly lower than the rate reported in some SIOP series, which is greater than 60% [19, 24] , but greater than other SIOP series, which is less than 40% [17, 25] [12, 16] . From the above result, we can conclude the importance of preoperative chemotherapy in downstaging of Wilm's tumours (downstage of higher stages to stage I so increase the incidence of stage I disease) subsequently easier surgery and can achieve complete surgical resection.
In our study, tumours were localized in the left kidney in 55% of patients and in 51.5 and 54.4% of Japanese and Egyptian patients, respectively; there was no statistically significant difference and this was similar to that in previous studies that reported that the left kidney was involved more frequently than the right kidney [10, [28] [29] [30] [31] [32] .
Three KU patients (7.5%) and two AU patients (6%) had a bilateral renal tumour. However, six SECI patients (7.6%) had a bilateral renal tumour; previous studies have reported the incidence of bilateral Wilm's tumours to range from 4 to 10% [10, 14, 15, 17, 27, [33] [34] [35] .
Histopathologically, 17.5% of KU, 8.8% of SECI and 9% of AU patients had an unfavourable histology. In NWTS3, the rate of an unfavourable histology was 11.2% [36] . In contrast, in the SIOP-9/GPOH study, the rate of the presence of an anaplastic Wilm's tumour was 7.5% [18] . There is a higher incidence of an unfavourable histology among Japanese patients; the exact cause for this is unknown, but a study carried out at Shanghai Children's Medical Center, China, reported that the incidence of Wilm's tumours with an unfavourable histology (including anaplasia, clear cell sarcoma and rhabdoid tumours) was 30%.
Slightly more than 1% (one patient 1.3%) of the patients in the SECI group received the wrong preoperative chemotherapy for benign disease (xanthogranulomatous pyelonephritis); SIOP studies have reported that, if a tumour has typical imaging and clinical features of a Wilm's tumour, chemotherapy should be started without histological confirmation. Thus, 1% of children with a noncancerous renal lesion receive chemotherapy [37] . The UKW3 trial reported that 12% of renal tumours with typical features of Wilm's tumours on imaging studies were found to be non-Wilm's tumours on a prechemotherapy biopsy [38] . On SIOP 93-01, approximately 5% of lesions in patients treated with chemotherapy were ultimately found not to be Wilm's tumours and 1.8% of lesions were found to be benign [39] . Xanthogranulomatous pyelonephritis is rare in children and is difficult to diagnose preoperatively, especially when the signs of sepsis are not prominent [40] ; also, preoperative chemotherapy may induce pathological changes similar to the pathology picture of xanthogranulomatous pyelonephritis. However, all patients in the KU and AU groups were accurately diagnosed histopathologically and a proper postoperative management was initiated.
In the SECI group, in patients treated by preoperative chemotherapy on the basis of the SIOP protocol, the incidence of intraoperative tumour rupture was 0%, whereas in Japanese patients treated according to the NWTS protocol, the incidence was 15 and 21% in AU. The UKW3 reported that there were no tumour ruptures among the 102 patients in the preoperative chemotherapy group compared with 15 (14.7%) among the 103 patients randomized to immediate nephrectomy [41] . This result shows the importance of preoperative chemotherapy in minimizing intraoperative tumour spillage. 
In SECI patients, the incidence of incomplete resection was 10% and the rate of recurrence was 5%. In the KU group, incomplete resection was encountered in nine (22.5%) of 40 patients; three (33.3%) of these patients died and two of them developed postoperative recurrence. Among 40 patients, seven (17.5%) died during the course of follow-up and four (57%) had an unfavourable histopathology (three cases of a rhabdoid tumour of the kidney and one case clear cell sarcoma of the kidney). Six of 40 patients (15%) developed postoperative recurrence; five of these (83%) patients died. This result is in agreement with the reports from early studies that reported that the long-term survival rate after recurrence of a Wilm's tumour hardly reached 30% [42] .
The intra operative tumor rupture increase incidence of local recurrence with its gloom outcome.
The 5-year overall survival rate for KU was 82.5 and 77% for AU patients. When all patients are considered (without exclusion of patients lost follow up) and when abandonment included the overall survival was 80%. There was no statistically significant difference between the two groups.
The major advantages of preoperative chemotherapy in the treatment of Wilm's tumours are as follows: (i) a reduction in the dose of adjuvant chemotherapy as a result of preoperative downstaging of the tumour; (ii) a decrease in the incidence of intraoperative tumour ruptures; and (iii) a reduced need for postoperative radiotherapy in cases of metastatic disease. Besides its acute toxicity, the major disadvantage of preoperative chemotherapy is the lack of a valid histopathological diagnosis before beginning the treatment, with a consequent risk of treating benign lesions resistant to chemotherapy. However, this is estimated to be 1.5-5% and, therefore, is acceptable when balanced against the advantages of the strategy.
Although North America and Europe have different philosophies on preoperative chemotherapy, the overriding message is that most patients with Wilm's tumours survive in the long term, irrespective of the sequence of therapeutic interventions.
Conclusion
Egyptian patients with Wilm's tumours presented at a younger age and had a lower incidence of an unfavourable histology compared with Japanese patients. Preoperative chemotherapy increased the rate of stage I disease and decreased the incidence of intraoperative tumour rupture and relapse. However, there is a possibility that chemotherapy may have been administered in patients with benign disease.
